42 found
Order:
Disambiguations:
Jeffrey P. Kahn [26]Jeffrey Kahn [16]Jeffrey Paul Kahn [1]
  1.  10
    James F. Childress, Ruth R. Faden, Ruth D. Gaare, Lawrence O. Gostin, Jeffrey Kahn, Richard J. Bonnie, Nancy E. Kass, Anna C. Mastroianni, Jonathan D. Moreno & Phillip Nieburg (2002). Public Health Ethics: Mapping the Terrain. Journal of Law, Medicine & Ethics 30 (2):170-178.score: 1.17033
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   42 citations  
  2.  3
    Susan M. Wolf, Frances P. Lawrenz, Charles A. Nelson, Jeffrey P. Kahn, Mildred K. Cho, Ellen Wright Clayton, Joel G. Fletcher, Michael K. Georgieff, Dale Hammerschmidt, Kathy Hudson, Judy Illes, Vivek Kapur, Moira A. Keane, Barbara A. Koenig, Bonnie S. LeRoy, Elizabeth G. McFarland, Jordan Paradise, Lisa S. Parker, Sharon F. Terry, Brian van Ness & Benjamin S. Wilfond (2008). Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations. Journal of Law, Medicine & Ethics 36 (2):219-248.score: 1.15267
    No consensus yet exists on how to handle incidental fnd-ings in human subjects research. Yet empirical studies document IFs in a wide range of research studies, where IFs are fndings beyond the aims of the study that are of potential health or reproductive importance to the individual research participant. This paper reports recommendations of a two-year project group funded by NIH to study how to manage IFs in genetic and genomic research, as well as imaging research. We conclude that researchers (...)
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   17 citations  
  3.  18
    Allen E. Buchanan, Andrea Califano, Jeffrey Kahn, Elizabeth McPherson, John A. Robertson & Baruch A. Brody (2002). Pharmacogenetics: Ethical Issues and Policy Options. Kennedy Institute of Ethics Journal 12 (1):1-15.score: 1.10899
    : Pharmacogenetics offers the prospect of an era of safer and more effective drugs, as well as more individualized use of drug therapies. Before the benefits of pharmacogenetics can be realized, the ethical issues that arise in research and clinical application of pharmacogenetic technologies must be addressed. The ethical issues raised by pharmacogenetics can be addressed under six headings: (1) regulatory oversight, (2) confidentiality and privacy, (3) informed consent, (4) availability of drugs, (5) access, and (6) clinicians' changing responsibilities in (...)
    Direct download (7 more)  
     
    Export citation  
     
    My bibliography   5 citations  
  4.  11
    Leili Fatehi, Susan M. Wolf, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Jeffrey P. Kahn, Cortney Jones, Stephen A. Campbell, Rebecca S. Dresser, Arthur G. Erdman, Christy L. Haynes, Robert A. Hoerr, Linda F. Hogle, Moira A. Keane, George Khushf, Nancy M. P. King, Efrosini Kokkoli, Gary Marchant, Andrew D. Maynard, Martin Philbert, Gurumurthy Ramachandran, Ronald A. Siegel & Samuel Wickline (2012). Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field. Journal of Law, Medicine & Ethics 40 (4):716-750.score: 1.10817
    The nanomedicine field is fast evolving toward complex, “active,” and interactive formulations. Like many emerging technologies, nanomedicine raises questions of how human subjects research (HSR) should be conducted and the adequacy of current oversight, as well as how to integrate concerns over occupational, bystander, and environmental exposures. The history of oversight for HSR investigating emerging technologies is a patchwork quilt without systematic justification of when ordinary oversight for HSR is enough versus when added oversight is warranted. Nanomedicine HSR provides an (...)
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  5.  1
    Jeffrey P. Kahn (2006). What Happens When Politics Discovers Bioethics? Hastings Center Report 36 (3):10-10.score: 1.10563
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  6.  9
    Susan M. Wolf & Jeffrey P. Kahn (2005). Bioethics Matures:. Hastings Center Report 35 (4):22-24.score: 1.10477
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  7.  1
    Baruch Brody, Nancy Dubler, Jeff Blustein, Arthur Caplan, Jeffrey P. Kahn, Nancy Kass, Bernard Lo, Jonathan Moreno, Jeremy Sugarman & Laurie Zoloth (2002). The Task Force Responds. Hastings Center Report 32 (3):22-23.score: 1.10352
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  8. Stella Gonzalez Arnal, Donald Chalmers, David Kum-Wah Chan, Margaret Coffey, Jo Ann T. Croom, Mylène Deschênes, Henrich Ganthaler, Yuri Gariev, Ryuichi Ida, Jeffrey P. Kahn, Martin O. Makinde, Anna C. Mastroianni, Katharine R. Meacham, Bushra Mirza, Michael J. Morgan, Dianne Nicol, Edward Reichman, Susan E. Wallace & Larissa P. Zhiganova (2004). Cross-Cultural Biotechnology: A Reader. Rowman & Littlefield Publishers.score: 1.10328
    This book is a rich blend of analyses by leading experts from various cultures and disciplines. A compact introduction to a complex field, it illustrates biotechnology's profound impact upon the environment and society. Moreover, it underscores the vital relevance of cultural values. This book empowers readers to more critically assess biotechnology's value and effectiveness within both specific cultural and global contexts.
     
    Export citation  
     
    My bibliography   1 citation  
  9.  33
    Jeffrey P. Kahn & Anna C. Mastroianni (2004). Creating a Stem Cell Donor: A Case Study in Reproductive Genetics. Kennedy Institute of Ethics Journal 14 (1):81-96.score: 1.10315
    : During the nearly 10 years since its introduction, preimplantation genetic diagnosis (PGD) has been used predominantly to avoid giving birth to a child with identified genetic disease. Recently, PGD was used by a couple not only to test IVF-created embryos for genetic disease, but also to test for a nondisease trait related to immune compatibility with a child in the family in need of an hematopoetic stem cell transplant. This article describes the case, raises some ethical and policy issues, (...)
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  10.  17
    Robert E. McKeown, Douglas L. Weed, Jeffrey P. Kahn & Michael A. Stoto (2003). American College of Epidemiology Ethics Guidelines: Foundations and Dissemination. Science and Engineering Ethics 9 (2):207-214.score: 1.10245
    Epidemiology is a core science of public health, focusing on research related to the distribution and determinants of both positive and adverse health states and events and on application of knowledge gained to improve public health. The American College of Epidemiology (ACE) is a professional organization devoted to the professional practice of epidemiology. As part of that commitment, and in response to concerns for more explicit attention to core values and duties of epidemiologists in light of emerging issues and increased (...)
    Direct download (7 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  11.  2
    Jeffrey Kahn & Anna Mastroianni (2004). Looking Forward in Bioethics. Journal of Law, Medicine & Ethics 32 (2):196-197.score: 1.10235
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  12.  2
    Jeffrey Kahn (2014). Lessons Learned: Challenges in Applying Current Constraints on Research on Chimpanzees to Other Animals. Theoretical Medicine and Bioethics 35 (2):97-104.score: 1.10231
    The Institute of Medicine (IOM) Committee on the Necessity of the Use of Chimpanzees in Biomedical and Behavioral Research made a series of recommendations that, as of an announcement on June 26, 2013, the National Institutes of Health (NIH) is turning into implemented guidelines. Many advocates, including some researchers and scholars, have suggested that the Committee’s recommendations could be applied successfully to other animal species. This article examines, from my perspective as the IOM Committee’s chair, some of the most important (...)
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  13.  10
    Susan M. Wolf, Jeffrey P. Kahn & John E. Wagner (2003). Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines & Limits. Journal of Law, Medicine & Ethics 31 (3):327-339.score: 1.10229
  14.  7
    John A. Robertson, Jeffrey P. Kahn & John E. Wagner (forthcoming). Conception. Hastings Center Report.score: 1.10222
    Direct download  
     
    Export citation  
     
    My bibliography  
  15.  5
    Anna Mastroianni & Jeffrey Kahn (2001). Swinging on the Pendulum: Shifting Views of Justice in Human Subjects Research. Hastings Center Report 31 (3):22-24.score: 1.10215
    Direct download (5 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  16.  5
    Susan M. Wolf & Jeffrey P. Kahn (forthcoming). Bioethics Matures: The Field Faces the Future. Hastings Center Report.score: 1.10212
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  17.  2
    John A. Robertson, Jeffrey P. Kahn & John E. Wagner (2002). CONCEPTION to Obtain Hematopoietic Stem Cells. Hastings Center Report 32 (3):34-40.score: 1.1021
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  18.  4
    Jeffrey P. Kahn (1991). Genetic Harm: Bitten by the Body That Keeps You? Bioethics 5 (4):289–308.score: 1.10195
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  19.  2
    Jeffrey Kahn (2004). Genetic Counselors' Impact on the Genetics Revolution: Recommendations of an Informed Outsider. Bioethics Examiner 8.score: 1.10177
    Direct download  
     
    Export citation  
     
    My bibliography  
  20.  1
    Jeffrey Kahn (2002). Commentary: Making the Most of Strangers' Altruism. Journal of Law, Medicine & Ethics 30 (3):446-447.score: 1.10174
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  21.  36
    Jeffrey P. Kahn (2003). Three Views of Organ Procurement Policy: Moving Ahead or Giving Up? Kennedy Institute of Ethics Journal 13 (1):45-50.score: 1.10128
    : The supply of organs for transplant remains inadequate to meet the needs of waiting patients, in spite of many programs and approaches to increase rates of donation. Over the years there have been numerous proposals to introduce schemes that would move toward the outright sale of organs. Three articles in this issue of the Journal propose methods for increasing organ supply—two by moving toward a market approach and the third by advocating a change in social culture. All three suffer (...)
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography  
  22.  6
    Tom L. Beauchamp, Howard Brody, Franklin G. Miller, Alexander S. Curtis, Martina Darragh, Patricia Milmoe, Ronald M. U. S. Green, Sharona Hoffman, Edmund G. Howe & Jeffrey P. Kahn (2003). By Author BAGHERI, Alireza. Criticism of “Brain. Kennedy Institute of Ethics Journal 13 (4):407-09.score: 1.10109
    No categories
    Direct download  
     
    Export citation  
     
    My bibliography  
  23.  8
    Jeffrey Kahn (2001). Can We Broker Eggs Without Making Omelets? American Journal of Bioethics 1 (4):14 – 15.score: 1.10042
  24.  1
    Jeffrey Kahn (2012). Raising the Bar: The Implications of the IOM Report on the Use of Chimpanzees in Research. Hastings Center Report 42 (s1):S27 - S30.score: 1.10042
    Direct download (7 more)  
     
    Export citation  
     
    My bibliography  
  25.  2
    Jeffrey P. Kahn & Susan M. Wolf (2007). Understanding the Role of Genetics in Disability Insurance. Journal of Law, Medicine & Ethics 35 (s2):5-5.score: 1.10037
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  26.  4
    Jeffrey P. Kahn (2007). Baseball, Alcohol and Public Health. American Journal of Bioethics 7 (7):3.score: 1.10019
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography  
  27.  5
    Jeffrey P. Kahn (1991). Commentary on Zohar's "Prospects For'genetic Therapy'- Can a Person Benefit From Being Altered?". Bioethics 5 (4):312–317.score: 1.10018
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography  
  28.  5
    Jeffrey Kahn (2007). What Vaccination Programs Mean for Research. American Journal of Bioethics 7 (3):3 – 4.score: 1.10018
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  29.  3
    Susan M. Wolf & Jeffrey P. Kahn (2007). Genetic Testing and the Future of Disability Insurance: Ethics, Law & Policy. Journal of Law, Medicine & Ethics 35 (s2):6-32.score: 1.10016
    Predictive genetic testing poses fundamental questions for disability insurance, a crucial resource funding basic needs when disability prevents income from work. This article, from an NIH-funded project, presents the first indepth analysis of the challenging issues: Should disability insurers be permitted to consider genetics and exclude predicted disability? May disabilities with a recognized genetic basis be excluded from coverage as pre-existing conditions? How can we assure that private insurers writing individual and group policies, employers, and public insurers deal competently and (...)
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  30.  3
    Jeffrey P. Kahn (2007). Organs and Stem Cells: Policy Lessons and Cautionary Tales. Hastings Center Report 37 (2):11-12.score: 1.10012
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography  
  31.  2
    Jeffrey P. Kahn (2007). Why Public Health and Politics Don't Mix. American Journal of Bioethics 7 (11):3 – 4.score: 1.10011
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography  
  32.  2
    Jeffrey P. Kahn & Anna C. Mastroianni (1996). Introduction. Kennedy Institute of Ethics Journal 6 (3):ix-xi.score: 1.1001
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  33.  2
    Jeffrey P. Kahn (2009). Commentary: Who's Afraid of the RAC? Lessons From the Oversight of Controversial Science. Journal of Law, Medicine & Ethics 37 (4):685-687.score: 1.10009
    This commentary asks what we can learn from our oversight of controversial science and how can we do better in the future? After briefly examining the history of gene transfer research oversight, some observations are offered for the oversight of nanobiotechnology and other emerging areas of science.
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  34.  1
    Anna C. Mastroianni & Jeffrey P. Kahn (1996). Introduction. Kennedy Institute of Ethics Journal 6 (3):ix-xi.score: 1.10005
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  35.  0
    Carl Elliott & Jeffrey Kahn (1994). Docs on the Box Or, How We Learned to Stop Worrying and Love the Tube. Hastings Center Report 24 (6):22-23.score: 1.1
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  36.  0
    Jeffrey Kahn (2008). An Unprotected Public. American Journal of Bioethics 8 (6):3 – 4.score: 1.1
    Direct download (5 more)  
     
    Export citation  
     
    My bibliography  
  37.  0
    Jeffrey Kahn (2002). It's a Small World After All: Ethics and the Response to SARS. Hastings Center Report 33 (3):6-6.score: 1.1
    No categories
    Direct download  
     
    Export citation  
     
    My bibliography  
  38.  0
    Jeffrey P. Kahn (2005). Letter to the Editor. American Journal of Bioethics 5 (3):W13-W13.score: 1.1
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  39. Jeffrey Kahn & Anna Mastroianni (2009). The Implications of Public Health for Bioethics. In Bonnie Steinbock (ed.), The Oxford Handbook of Bioethics. OUP Oxfordscore: 1.1
     
    Export citation  
     
    My bibliography  
  40.  0
    Anna Mastroianni & Jeffrey Kahn (1996). Remedies for Human Subjects of Cold?War Research: Recommendations of the Advisory Committee. Journal of Law, Medicine & Ethics 24 (2):118-126.score: 1.1
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography  
  41. Anna Mastroianni & Jeffrey Kahn (2001). The? Etv. Hastings Center Report 21:15.score: 1.1
     
    Export citation  
     
    My bibliography  
  42. Susan M. Wolf, Jeffrey P. Kahn & John E. Wagner (2003). Clinical, Ethical, and Legal Issues in Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor. Journal of Law, Medicine & Ethics 31:327-39.score: 1.1
     
    Export citation  
     
    My bibliography